Amid a surge of targeted cancer meds, AstraZeneca, Amgen and Roche lead team promoting biomarker testing
29th April 2021 Uncategorised 0 Amid a surge of targeted cancer meds, AstraZeneca, Amgen and Roche lead team promoting biomarker testing
sharon.coey
Thu, 04/29/2021 – 07:13
More: Amid a surge of targeted cancer meds, AstraZeneca, Amgen and Roche lead team promoting biomarker testing
Source: fierce
